FMT

FMT

2901 bookmarks
Custom sorting
An overview of Clostridioides difficile and faecal microbiota transplant: implications for nursing practice - PubMed
An overview of Clostridioides difficile and faecal microbiota transplant: implications for nursing practice - PubMed
Clostridioides difficile bacteria can cause excessive diarrhoea in patients, leading to further complications, such as severe dehydration and sepsis. Although C.difficile bacteria tend to reside harmlessly in many people's bowels, prolonged antibiotic use can alter the bacterial balanc …
·pubmed.ncbi.nlm.nih.gov·
An overview of Clostridioides difficile and faecal microbiota transplant: implications for nursing practice - PubMed
Fecal microbiota transplantation improves chicken growth performance by balancing jejunal Th17/Treg cells - PubMed
Fecal microbiota transplantation improves chicken growth performance by balancing jejunal Th17/Treg cells - PubMed
These findings suggested that imbalanced Th17/Treg cells decreased chicken growth performance, while FMT-reshaped gut microbiota, i.e., higher Lactobacilli, increased chicken growth performance by balancing Th17/Treg cells. Video Abstract.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation improves chicken growth performance by balancing jejunal Th17/Treg cells - PubMed
Silke Salavati DVM 🐈🐕 PhD DipECVIM-CA FHEA💙🇪🇺 on Twitter
Silke Salavati DVM 🐈🐕 PhD DipECVIM-CA FHEA💙🇪🇺 on Twitter
“More #news: I am #proud to say we have established our #FMT bank @TheDickVet. Well screened donors, FMTs ready to go! Available for both #dogs and #cats! #InternalMedicine #gastroenterology #microbiome #guthealth #onwardsandupwards #cuttingedge #bestcare #innovationinhealthcare”
·twitter.com·
Silke Salavati DVM 🐈🐕 PhD DipECVIM-CA FHEA💙🇪🇺 on Twitter
Why your GP may soon prescribe a gut bacteria DRUG to treat IBS
Why your GP may soon prescribe a gut bacteria DRUG to treat IBS
Keeping the community of microorganisms (including bacteria, fungi and viruses) that live in the digestive tract balanced helps keep us healthy, while an imbalance can cause illness.
·dailymail.co.uk·
Why your GP may soon prescribe a gut bacteria DRUG to treat IBS
The Global Live Biotherapeutic Products And Microbiome CDMO Market size is expected to reach $159.1 million by 2029, rising at a market growth of 42.5% CAGR during the forecast period
The Global Live Biotherapeutic Products And Microbiome CDMO Market size is expected to reach $159.1 million by 2029, rising at a market growth of 42.5% CAGR during the forecast period
Diabetes is one of the major applications of live biotherapeutic products and microbiome CDMO market and captured more than 35% share in the market during...
·news.google.com·
The Global Live Biotherapeutic Products And Microbiome CDMO Market size is expected to reach $159.1 million by 2029, rising at a market growth of 42.5% CAGR during the forecast period
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.
·pubmed.ncbi.nlm.nih.gov·
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease - PubMed
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Across five clinical trials, RBL was well tolerated in adults with rCDI. In aggregate, these data consistently demonstrated the safety of RBL.
·pubmed.ncbi.nlm.nih.gov·
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials - PubMed
Effects of gut microbiota on neurodegenerative diseases - PubMed
Effects of gut microbiota on neurodegenerative diseases - PubMed
A progressive degradation of the brain's structure and function, which results in a reduction in cognitive and motor skills, characterizes neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). …
·pubmed.ncbi.nlm.nih.gov·
Effects of gut microbiota on neurodegenerative diseases - PubMed
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Human gut microbiota are critical to both the development of and recovery from Clostridioides difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause further imbalances in the gut microbiota, termed dysbiosis, complicating recovery. A variety of microbio …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies - PubMed
Safety and Efficacy of Fecal Microbiota Transplantation in Treatment of Inflammatory Bowel Disease in the Pediatric Population: A Systematic Review and Meta-Analysis - PubMed
Safety and Efficacy of Fecal Microbiota Transplantation in Treatment of Inflammatory Bowel Disease in the Pediatric Population: A Systematic Review and Meta-Analysis - PubMed
Background and Aims: Fecal microbiota transplantation (FMT) has been increasingly studied in the inflammatory bowel disease (IBD) population. However, most studies have focused on the adult population, and the safety and efficacy of FMT in a pediatric population is less well understood. This …
·pubmed.ncbi.nlm.nih.gov·
Safety and Efficacy of Fecal Microbiota Transplantation in Treatment of Inflammatory Bowel Disease in the Pediatric Population: A Systematic Review and Meta-Analysis - PubMed
Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach - PubMed
Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach - PubMed
Individuals with nonalcoholic fatty liver disease (NAFLD) have an altered gut microbiota composition. Moreover, hepatic DNA methylation may be altered in the state of NAFLD. Using a fecal microbiota transplantation (FMT) intervention, we aimed to investigate whether a change in gut microbiota compos …
·pubmed.ncbi.nlm.nih.gov·
Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach - PubMed
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis - PubMed
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis - PubMed
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also predispose patients to immune-related adverse events like immune-mediated colitis (IMC). Given the association between gut bacteria with response to ICI therapy and subsequent IMC, fecal microbiota transplan …
·pubmed.ncbi.nlm.nih.gov·
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis - PubMed
Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats - PubMed
Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats - PubMed
A microbial network involving Muribaculaceae and other oxalate-degrading bacteria achieved by FMT was capable of reducing urinary oxalate excretion and CaOx crystal deposition in the kidney through increasing intestinal oxalate degradation. FMT may exert a renoprotective function in oxalate-related …
·pubmed.ncbi.nlm.nih.gov·
Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats - PubMed
Incorporating FMT Treatment Into Clinical Practice
Incorporating FMT Treatment Into Clinical Practice
Candace Cotto, RN, reviews the process of incorporating fecal microbiota, live-jslm treatment into clinical practice, what patients can expect, and the room sanitation process after the procedure.
·news.google.com·
Incorporating FMT Treatment Into Clinical Practice
Christian Hvas on Twitter
Christian Hvas on Twitter
Continuing the development of #FMT capsules to improve gut microbiome in patients with life-threatening diseases. Thanks @HepGas @AarhusUni_int @Innofond @novonordiskfond pic.twitter.com/Wm1MrSl8un— Christian Hvas (@ChristianHvas) June 11, 2023
·twitter.com·
Christian Hvas on Twitter
Harry Sokol on Twitter
Harry Sokol on Twitter
We are beyond associations. An active role of the altered gut #microbiota is demonstrated in #IBD (see #FMT studies notably). #Circular_Causality https://t.co/HZdX2JaKji— Harry Sokol (@h_sokol) June 7, 2023
·twitter.com·
Harry Sokol on Twitter